Medical

Lithium Followed Valproate Adverse Events in Schizophrenia Agitation Case

by
Lithium Followed Valproate Adverse Events in Schizophrenia Agitation Case

TL;DR: A 2026 study in Psychiatry and Clinical Neurosciences Reports described a treatment-resistant residual-phase schizophrenia case in which valproate helped agitation but caused hypoglycemia and pancytopenia, while lithium augmentation was followed by lower hostility and excitement scores. Key Findings 49-year-old patient: The case involved a Japanese woman with chronic treatment-resistant schizophrenia and persistent agitation, aggression, …

Read more

GPR30 Estrogen Receptor May Link Hormone Fluctuations to Migraine Pathophysiology

by
GPR30 Estrogen Receptor May Link Hormone Fluctuations to Migraine Pathophysiology

TL;DR: A 2026 review in Journal of Pain Research argued that G protein-coupled receptor 30 (GPR30/GPER), a membrane estrogen receptor, could help connect estrogen fluctuations with migraine biology. Key Findings Female-predominant migraine: The review notes a female-to-male migraine prevalence ratio of about 2:1 to 3:1. Menstrual migraine link: About 50% to 60% of female migraineurs …

Read more

tDCS Plus Cognitive Training Gave Short-Term Cognitive Benefit

by
tDCS Plus Cognitive Training Gave Short-Term Cognitive Benefit

TL;DR: A 2026 systematic review posted on medRxiv found that transcranial direct current stimulation (tDCS), a weak noninvasive brain-stimulation method, added to cognitive training produced a small short-term cognitive benefit across 27 trials, but the effect faded at follow-up and the evidence certainty was very low. Key Findings 27 controlled studies: The meta-analysis included 1,012 …

Read more

Targeted PGx Testing Found Actionable Depression Drug-Gene Results

by
Targeted PGx Testing Found Actionable Depression Drug-Gene Results

TL;DR: A 2026 study in The Pharmacogenomics Journal tested pharmacogenomic (PGx) depression care, meaning medication guidance based on drug-gene interactions; targeting Veterans already taking antidepressants with common PGx interactions raised the actionable-result rate to 30%, but immediate test-result access did not improve Patient Health Questionnaire-9 (PHQ-9) depression scores over 12 weeks. Key Findings 60 Veterans …

Read more

Most NHS Psychiatric Trusts Could Not Report Parent-Patient Data

by
Most NHS Psychiatric Trusts Could Not Report Parent-Patient Data

TL;DR: A 2026 study in BJPsych Bulletin used Freedom of Information requests and found that most English NHS trusts providing in-patient psychiatric care were unable to report basic data on which patients were parents of children under 18. Key Findings 50 trusts contacted: Researchers sent Freedom of Information requests to all English NHS trusts providing …

Read more

Human Substantia Nigra Neurons Reflected Recent Reward History

by
Human Substantia Nigra Neurons Reflected Recent Reward History

TL;DR: A 2026 iScience study recorded human substantia nigra neurons during Parkinson’s surgery and found that putative dopamine-neuron firing was higher after a prior reward, while the next response was modestly faster. Key Findings Direct human recordings: Researchers recorded 27 substantia nigra neurons across 13 sessions in 11 Parkinson’s disease patients undergoing deep-brain stimulation surgery. …

Read more

Slow-Wave EEG-fMRI Maps Could Track Brain Network Deviation

by
Slow-Wave EEG-fMRI Maps Could Track Brain Network Deviation

TL;DR: A 2026 iScience study used simultaneous EEG-fMRI from 24 healthy adults to build reference maps for slow-wave events (SWEs), brief sleep-related brain waves, and proposed SloCAD as a way to measure how an individual brain deviates from healthy slow-wave network patterns. Key Findings Two healthy cohorts were mapped: Researchers analyzed simultaneous EEG-fMRI sleep recordings …

Read more

SLC35F2 Solved a Queuosine Transport Mystery

by
SLC35F2 Solved a Queuosine Transport Mystery

TL;DR: A 2025 study in PNAS found that sLC35F2 emerged as the high-specificity transporter for queuine and queuosine, linking gut-derived micronutrients to tRNA modification and the cell’s protein-translation machinery. Key Findings 30-year transporter mystery: Scientists had suspected a selective queuine transporter for more than three decades. SLC35F2 carried Q and q: The study identifies SLC35F2 …

Read more

Semaglutide Reduced Heavy Alcohol Drinking by 13.7 Percentage Points vs Placebo in 26-Week Trial of Adults With AUD and Obesity

by
Semaglutide Reduced Heavy Alcohol Drinking by 13.7 Percentage Points vs Placebo in 26-Week Trial of Adults With AUD and Obesity

TL;DR: A 2026 randomized double-blind placebo-controlled trial in The Lancet (N=108 adults with both moderate-to-severe alcohol use disorder and obesity) found that 26 weeks of once-weekly 2.4 mg semaglutide reduced heavy drinking days by 41.1 percentage points compared with a 26.4-point reduction on placebo — a 13.7-point treatment difference, with parallel drops in alcohol craving, …

Read more

Rostral Prefrontal Gradient Predicted Creativity in Frontotemporal Dementia

by
Rostral Prefrontal Gradient Predicted Creativity in Frontotemporal Dementia

TL;DR: A 2026 study in Brain found that creativity in behavioral variant frontotemporal dementia tracked a rostral prefrontal cortex gradient, meaning the functional separation between default-mode and executive-control networks predicted creative performance. Key Findings 56-person clinical sample: researchers compared 27 patients with behavioral variant frontotemporal dementia (bvFTD) against 29 control participants from the ECOCAPTURE cohort. …

Read more

+ Load more